One of the microcap pharma stocks engaged in the manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms, specializing in cephalosporin antibiotics for global markets. The stock hit a 5 percent upper circuit after reporting a 399.36 percent YOY increase in net profit.  Stock Price Movement With a market capitalization of Rs. 796.80 crores, … Continue reading Pharma stock hits 5% upper circuit after reporting 399% YoY increase in net profit